Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 3
2019 2
2020 4
2021 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Understanding Nonadherence to Tuberculosis Medications in India Using Urine Drug Metabolite Testing: A Cohort Study.
Subbaraman R, Thomas BE, Kumar JV, Thiruvengadam K, Khandewale A, Kokila S, Lubeck-Schricker M, Ranjith Kumar M, Gaurkhede GR, Walgude AS, Hephzibah Mercy J, Kumbhar JD, Eliasziw M, Mayer KH, Haberer JE. Subbaraman R, et al. Open Forum Infect Dis. 2021 May 5;8(6):ofab190. doi: 10.1093/ofid/ofab190. eCollection 2021 Jun. Open Forum Infect Dis. 2021. PMID: 34250181 Free PMC article.
Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
Thomas BE, Kumar JV, Periyasamy M, Khandewale AS, Hephzibah Mercy J, Raj EM, Kokila S, Walgude AS, Gaurkhede GR, Kumbhar JD, Ovung S, Paul M, Rajkumar BS, Subbaraman R. Thomas BE, et al. J Med Internet Res. 2021 Jun 10;23(6):e23294. doi: 10.2196/23294. J Med Internet Res. 2021. PMID: 34110300 Free PMC article.
Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers.
Thomas BE, Kumar JV, Onongaya C, Bhatt SN, Galivanche A, Periyasamy M, Chiranjeevi M, Khandewale AS, Ramachandran G, Shah D, Haberer JE, Mayer KH, Subbaraman R. Thomas BE, et al. JMIR Mhealth Uhealth. 2020 Jul 31;8(7):e16634. doi: 10.2196/16634. JMIR Mhealth Uhealth. 2020. PMID: 32735220 Free PMC article.
Understanding pretreatment loss to follow-up of tuberculosis patients: an explanatory qualitative study in Chennai, India.
Thomas BE, Suresh C, Lavanya J, Lindsley MM, Galivanche AT, Sellappan S, Ovung S, Aravind A, Lincy S, Raja AL, Kokila S, Javeed B, Arumugam S, Mayer KH, Swaminathan S, Subbaraman R. Thomas BE, et al. BMJ Glob Health. 2020 Mar 2;5(2):e001974. doi: 10.1136/bmjgh-2019-001974. eCollection 2020. BMJ Glob Health. 2020. PMID: 32181000 Free PMC article.
15 results